US Stock MarketDetailed Quotes

CPHRF Cipher Pharmaceuticals Inc

Watchlist
  • 6.500
  • -0.036-0.55%
15min DelayClose May 31 16:00 ET
  • 6.429
  • -0.071-1.10%
Post 16:52 ET
156.73MMarket Cap7.22P/E (TTM)

Cipher Pharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
20.08%5.87M
2.36%21.16M
0.22%4.92M
26.63%6.07M
-4.86%5.29M
-9.79%4.89M
-5.78%20.68M
-16.11%4.91M
6.16%4.79M
-9.33%5.56M
Operating revenue
20.08%5.87M
2.36%21.16M
0.22%4.92M
26.63%6.07M
-4.86%5.29M
-9.79%4.89M
-5.78%20.68M
-16.11%4.91M
6.16%4.79M
-9.33%5.56M
Cost of revenue
7.98%1.06M
1.93%4.07M
2.03%955K
25.12%1.08M
-1.03%1.06M
-13.08%977K
8.36%3.99M
0.43%936K
8.72%860K
2.98%1.07M
Gross profit
23.10%4.81M
2.46%17.09M
-0.20%3.97M
26.96%4.99M
-5.77%4.23M
-8.92%3.91M
-8.63%16.68M
-19.25%3.97M
5.61%3.93M
-11.85%4.49M
Operating expense
12.41%1.76M
25.33%7.06M
13.92%1.6M
14.34%1.97M
72.96%1.93M
12.20%1.56M
8.33%5.63M
36.68%1.4M
1.12%1.72M
-11.98%1.12M
Selling and administrative expenses
20.08%1.42M
22.57%5.39M
25.00%1.24M
14.84%1.55M
53.85%1.42M
1.02%1.19M
-13.93%4.4M
-3.22%992K
-20.85%1.35M
-21.91%923K
-General and administrative expense
20.08%1.42M
22.57%5.39M
25.00%1.24M
14.84%1.55M
53.85%1.42M
--1.19M
--4.4M
--992K
--1.35M
--923K
Research and development costs
28.57%45K
80.33%440K
22.06%83K
322.22%152K
335.90%170K
-46.15%35K
177.27%244K
--68K
--36K
-55.17%39K
Depreciation amortization depletion
-15.74%289K
24.06%1.23M
-19.94%273K
-20.41%269K
120.65%342K
121.29%343K
--989K
--341K
--338K
--155K
-Depreciation and amortization
-15.74%289K
24.06%1.23M
-19.94%273K
-20.41%269K
120.65%342K
121.29%343K
--989K
--341K
--338K
--155K
Operating profit
30.22%3.06M
-9.20%10.03M
-7.89%2.37M
36.79%3.02M
-31.88%2.3M
-19.08%2.35M
-15.38%11.05M
-33.97%2.57M
9.41%2.21M
-11.81%3.37M
Net non-operating interest income expense
56.34%555K
303.02%1.87M
107.87%555K
239.49%533K
1,193.94%427K
4,971.43%355K
680.00%464K
6,575.00%267K
1,844.44%157K
189.19%33K
Non-operating interest income
56.34%555K
303.02%1.87M
107.87%555K
239.49%533K
1,193.94%427K
4,971.43%355K
--464K
--267K
--157K
1,000.00%33K
Other net income (expense)
-9,271.43%-642K
2,322.86%778K
696.84%757K
-502.78%-434K
697.33%448K
-58.82%7K
98.18%-35K
493.75%95K
89.71%-72K
-231.58%-75K
Gain on sale of security
-9,271.43%-642K
2,322.86%778K
696.84%757K
-502.78%-434K
697.33%448K
-58.82%7K
-139.77%-35K
493.75%95K
-224.14%-72K
-231.58%-75K
Income before tax
9.60%2.97M
10.47%12.68M
25.46%3.68M
36.03%3.12M
-4.72%3.17M
-7.36%2.71M
3.80%11.48M
-25.06%2.93M
75.06%2.3M
-13.36%3.33M
Income tax
-2,484.15%-1.96M
49.19%-7.7M
76.27%-3.97M
-988.86%-3.91M
-91.57%99K
-89.41%82K
-559.16%-15.16M
-1,615.57%-16.75M
-169.71%-359K
14.75%1.18M
Net income
87.47%4.92M
-23.48%20.38M
-61.10%7.66M
164.92%7.03M
42.70%3.07M
22.20%2.63M
243.34%26.64M
600.39%19.68M
233.42%2.65M
-23.58%2.15M
Net income continuous Operations
87.47%4.92M
-23.48%20.38M
-61.10%7.66M
164.92%7.03M
42.70%3.07M
22.20%2.63M
243.34%26.64M
600.39%19.68M
233.42%2.65M
-23.58%2.15M
Minority interest income
Net income attributable to the parent company
87.47%4.92M
-23.48%20.38M
-61.10%7.66M
164.92%7.03M
42.70%3.07M
22.20%2.63M
243.34%26.64M
600.39%19.68M
233.42%2.65M
-23.58%2.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
87.47%4.92M
-23.48%20.38M
-61.10%7.66M
164.92%7.03M
42.70%3.07M
22.20%2.63M
243.34%26.64M
600.39%19.68M
233.42%2.65M
-23.58%2.15M
Basic earnings per share
110.00%0.21
-21.90%0.82
-58.97%0.32
154.55%0.28
50.00%0.12
25.00%0.1
262.07%1.05
680.00%0.78
266.67%0.11
-27.27%0.08
Diluted earnings per share
100.00%0.2
-22.33%0.8
-60.53%0.3
170.00%0.27
50.00%0.12
25.00%0.1
255.17%1.03
660.00%0.76
233.33%0.1
-20.00%0.08
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 20.08%5.87M2.36%21.16M0.22%4.92M26.63%6.07M-4.86%5.29M-9.79%4.89M-5.78%20.68M-16.11%4.91M6.16%4.79M-9.33%5.56M
Operating revenue 20.08%5.87M2.36%21.16M0.22%4.92M26.63%6.07M-4.86%5.29M-9.79%4.89M-5.78%20.68M-16.11%4.91M6.16%4.79M-9.33%5.56M
Cost of revenue 7.98%1.06M1.93%4.07M2.03%955K25.12%1.08M-1.03%1.06M-13.08%977K8.36%3.99M0.43%936K8.72%860K2.98%1.07M
Gross profit 23.10%4.81M2.46%17.09M-0.20%3.97M26.96%4.99M-5.77%4.23M-8.92%3.91M-8.63%16.68M-19.25%3.97M5.61%3.93M-11.85%4.49M
Operating expense 12.41%1.76M25.33%7.06M13.92%1.6M14.34%1.97M72.96%1.93M12.20%1.56M8.33%5.63M36.68%1.4M1.12%1.72M-11.98%1.12M
Selling and administrative expenses 20.08%1.42M22.57%5.39M25.00%1.24M14.84%1.55M53.85%1.42M1.02%1.19M-13.93%4.4M-3.22%992K-20.85%1.35M-21.91%923K
-General and administrative expense 20.08%1.42M22.57%5.39M25.00%1.24M14.84%1.55M53.85%1.42M--1.19M--4.4M--992K--1.35M--923K
Research and development costs 28.57%45K80.33%440K22.06%83K322.22%152K335.90%170K-46.15%35K177.27%244K--68K--36K-55.17%39K
Depreciation amortization depletion -15.74%289K24.06%1.23M-19.94%273K-20.41%269K120.65%342K121.29%343K--989K--341K--338K--155K
-Depreciation and amortization -15.74%289K24.06%1.23M-19.94%273K-20.41%269K120.65%342K121.29%343K--989K--341K--338K--155K
Operating profit 30.22%3.06M-9.20%10.03M-7.89%2.37M36.79%3.02M-31.88%2.3M-19.08%2.35M-15.38%11.05M-33.97%2.57M9.41%2.21M-11.81%3.37M
Net non-operating interest income expense 56.34%555K303.02%1.87M107.87%555K239.49%533K1,193.94%427K4,971.43%355K680.00%464K6,575.00%267K1,844.44%157K189.19%33K
Non-operating interest income 56.34%555K303.02%1.87M107.87%555K239.49%533K1,193.94%427K4,971.43%355K--464K--267K--157K1,000.00%33K
Other net income (expense) -9,271.43%-642K2,322.86%778K696.84%757K-502.78%-434K697.33%448K-58.82%7K98.18%-35K493.75%95K89.71%-72K-231.58%-75K
Gain on sale of security -9,271.43%-642K2,322.86%778K696.84%757K-502.78%-434K697.33%448K-58.82%7K-139.77%-35K493.75%95K-224.14%-72K-231.58%-75K
Income before tax 9.60%2.97M10.47%12.68M25.46%3.68M36.03%3.12M-4.72%3.17M-7.36%2.71M3.80%11.48M-25.06%2.93M75.06%2.3M-13.36%3.33M
Income tax -2,484.15%-1.96M49.19%-7.7M76.27%-3.97M-988.86%-3.91M-91.57%99K-89.41%82K-559.16%-15.16M-1,615.57%-16.75M-169.71%-359K14.75%1.18M
Net income 87.47%4.92M-23.48%20.38M-61.10%7.66M164.92%7.03M42.70%3.07M22.20%2.63M243.34%26.64M600.39%19.68M233.42%2.65M-23.58%2.15M
Net income continuous Operations 87.47%4.92M-23.48%20.38M-61.10%7.66M164.92%7.03M42.70%3.07M22.20%2.63M243.34%26.64M600.39%19.68M233.42%2.65M-23.58%2.15M
Minority interest income
Net income attributable to the parent company 87.47%4.92M-23.48%20.38M-61.10%7.66M164.92%7.03M42.70%3.07M22.20%2.63M243.34%26.64M600.39%19.68M233.42%2.65M-23.58%2.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 87.47%4.92M-23.48%20.38M-61.10%7.66M164.92%7.03M42.70%3.07M22.20%2.63M243.34%26.64M600.39%19.68M233.42%2.65M-23.58%2.15M
Basic earnings per share 110.00%0.21-21.90%0.82-58.97%0.32154.55%0.2850.00%0.1225.00%0.1262.07%1.05680.00%0.78266.67%0.11-27.27%0.08
Diluted earnings per share 100.00%0.2-22.33%0.8-60.53%0.3170.00%0.2750.00%0.1225.00%0.1255.17%1.03660.00%0.76233.33%0.1-20.00%0.08
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg